Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China

Published:2018-03-01 Issue:3 Volume:22 Page:300-305
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Fan Y-M.¹,Ding S-P.²,Bao Z-J.³,Wu L-M.⁴,Zhen L-B.³,Xia Q.³,Zhu M.³

Affiliation:

1. Department of Internal Medicine, Zhejiang University Hospital, Hangzhou

2. The National Education Base for Basic Medical Sciences, School of Medicine, Zhejiang University, Hangzhou

3. Zhejiang Prevention and Treatment Center of Tuberculosis, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou

4. Hangzhou Center for Disease Control and Prevention, Hangzhou, China

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A highly effective and inexpensive standardized treatment of multidrug-resistant tuberculosis: a multicenter prospective study in China;BMC Infectious Diseases;2021-08-19

2. Treatment outcomes of multidrug-resistant tuberculosis in Hangzhou, China, 2011 to 2015;Medicine;2020-07-24

3. Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study;BMC Infectious Diseases;2020-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP